Federal Register / Vol. 87, No. 79 / Monday, April 25, 2022 / Notices 24325 

Dated: April 20, 2022. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–08719 Filed 4–22–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; longitudinal 

and peripheral AD biomarkers in a diverse 

cohort of subjects. 

Date: June 1, 2022. 

Time: 9:00 a.m. to 12:30 p.m. 

Agenda: To review and evaluate 

cooperative agreement applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Bethesda, MD 20892, (Virtual Meeting). 

Contact Person: Maurizio Grimaldi, MD, 

Ph.D., Scientific Review Officer, National 

Institute on Aging, National Institutes of 

Health, 7201 Wisconsin Avenue, Room 

2C218, Bethesda, MD 20892, 301–496–9374, 

grimaldim2@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: April 20, 2022. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–08722 Filed 4–22–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR Panel: 

The Molecular and Cellular Causal Aspects 

of Alzheimer’s Disease. 

Date: June 2, 2022. 

Time: 10:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Linda MacArthur, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4187, 

Bethesda, MD 20892, 301–537–9986, 

macarthurlh@csr.nih.gov. 

Name of Committee: Surgical Sciences, 

Biomedical Imaging and Bioengineering 

Integrated Review Group; Bioengineering, 

Technology and Surgical Sciences Study 

Section. 

Date: June 6–7, 2022. 

Time: 8:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Khalid Masood, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5120, 

MSC 7854, Bethesda, MD 20892, 301–435– 

2392, masoodk@csr.nih.gov. 

Name of Committee: Cell Biology 

Integrated Review Group; Development—2 

Study Section. 

Date: June 6–7, 2022. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Rass M Shayiq, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2182, 

MSC 7818, Bethesda, MD 20892, (301) 435– 

2359, shayiqr@csr.nih.gov. 

Name of Committee: Biological Chemistry 

and Macromolecular Biophysics Integrated 

Review Group; Macromolecular Structure 

and Function A Study Section. 

Date: June 6–7, 2022. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: David R Jollie, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4166, 

MSC 7806, Bethesda, MD 20892, (301)–408– 

9072, jollieda@csr.nih.gov. 

Name of Committee: Bioengineering 

Sciences & Technologies Integrated Review 

Group; Modeling and Analysis of Biological 

Systems Study Section. 

Date: June 7–8, 2022. 

Time: 10:00 a.m. to 10:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Noffisat Oki, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (240) 627–3648, noffisat.oki@nih.gov. 

Name of Committee: Molecular, Cellular 

and Developmental Neuroscience Integrated 

Review Group; Molecular and Cellular 

Neuropharmacology Study Section. 

Date: June 9–10, 2022. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Vanessa S Boyce, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Rm. 4185, 

MSC 7850, Bethesda, MD 20892, (301) 402– 

3726, boycevs@csr.nih.gov. 

Name of Committee: Infectious Diseases 

and Immunology A Integrated Review Group; 

Pathogenic Eukaryotes Study Section. 

Date: June 9–10, 2022. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Tera Bounds, DVM, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3198, 

MSC 7808, Bethesda, MD 20892, 301 435– 

2306, boundst@csr.nih.gov. 

Name of Committee: Surgical Sciences, 

Biomedical Imaging and Bioengineering 

Integrated Review Group; Imaging Probes and 

Contrast Agents Study Section. 

Date: June 9–10, 2022. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Donald Scott Wright, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5108, 

MSC 7854, Bethesda, MD 20892, (301) 435– 

8363, wrightds@csr.nih.gov. 


khammond on DSKJM1Z7X2PROD with NOTICES
24326 Federal Register / Vol. 87, No. 79 / Monday, April 25, 2022 / Notices 

Name of Committee: Population Sciences 

and Epidemiology Integrated Review Group; 

Social Sciences and Population Studies A 

Study Section 

Date: June 9–10, 2022. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Suzanne Ryan, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3139, 

MSC 7770, Bethesda, MD 20892, (301) 435– 

1712, ryansj@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: April 20, 2022. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–08718 Filed 4–22–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

U.S. Immigration and Customs 

Enforcement 

[OMB Control Number 1653–0041] 

Agency Information Revision of a 

Currently Approved Collection: 

Designation of Attorney in Fact/ 

Revocation of Designation of Attorney 

in Fact 

AGENCY: U.S. Immigration and Customs 

Enforcement, Department of Homeland 

Security. 

ACTION: 30-Day notice. 

SUMMARY: In accordance with the 

Paperwork Reductions Act (PRA) of 

1995 the Department of Homeland 

Security (DHS), U.S. Immigration and 

Customs Enforcement (ICE) will submit 

the following Information Collection 

Request (ICR) to the Office of 

Management and Budget (OMB) for 

review and clearance. This information 

collection was previously published in 

the Federal Register on February 15, 

2022, allowing for a 60-day comment 

period. ICE received no comments in 

connection with the 60-day notice. The 

purpose of this notice is to allow an 

additional 30 days for public comments. 

DATES: Comments are encouraged and 

will be accepted until May 25, 2022. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of the publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

FOR FURTHER INFORMATION CONTACT: If 

you have questions related to this 

collection, call, or email John Monette, 

Revenue Management Branch, (802) 

288–7697, john.p.monette@ice.dhs.gov 

(This is not a toll-free number. 

Comments are not accepted via 

telephone message). 

SUPPLEMENTARY INFORMATION: 

Comments 

Written comments and suggestions 

from the public and affected agencies 

concerning the proposed collection of 

information should address one or more 

of the following four points: 

(1) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(2) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(3) Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

(4) Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses. 

Overview of This Information 

Collection 

(1) Type of Information Collection: 

Revision of a Currently Approved 

Collection. 

(2) Title of the Form/Collection: 

Designation of Attorney in Fact/ 

Revocation of Attorney in Fact. 

(3) Agency form number, if any, and 

the applicable component of the 

Department of Homeland Security 

sponsoring the collection: Form I–312/I– 

312A; U.S. Immigration and Customs 

Enforcement. 

(4) Affected public who will be asked 

or required to respond, as well as a brief 

abstract: Primary: State, Local, or Tribal 

Government. Section § 103.6, the 

Immigration and Nationality Act (INA), 

provides for the posting of surety or 

cash bonds. All bonds posted in 

immigration cases shall be executed on 

Form I–352, Immigration Bond, and 

secured with some form of collateral by 

an Obligor. In the case of a cash bond, 

the Obligor will deposit with U.S. 

Immigration and Customs Enforcement 

(ICE) the face value of the bond. The 

Obligor can designate a third party as an 

Attorney in Fact to accept on their 

behalf the return of the collateral 

security deposited to secure the surety 

bond upon cancellation of the bond or 

performance of the Obligor. The Form I– 

312, Designation of Attorney in Fact, is 

the instrument used by the Obligor to 

officially designate their Attorney in 

Fact. Upon receipt of a properly 

executed Form I–312, ICE Financial 

Operations will remit to the Attorney in 

Fact the principal and interest on the 

security deposit in the event of a bond 

cancellation, or the interest on the 

security deposit in the event of a bond 

breach. Immigration bonds might 

remain in place for years, and Obligors 

might choose to appoint a new Attorney 

in Fact as circumstances change. To 

ensure that ICE Financial Operations 

properly executes its fiduciary duties to 

the Obligor under the Form I–352 bond 

contract, and exercises due diligence in 

ensuring that remittances are made to 

the proper person, ICE uses Form I– 

312A as the document by which the 

Obligor could expressly indicate that a 

previously valid Form I–312 Attorney in 

Fact designation had been revoked. The 

requested revisions are specific to the 

instructions concerning obligor 

requirements and the attorney’s 

authority to perform acts necessary to 

receive proceeds of the bond. There are 

revisions to the I–312 instructions. The 

revisions relate to the obligor 

requirements and to the attorney’s 

authority to perform acts necessary to 

received bond proceeds. 

(5) An estimate of the total number of 

respondents and the time to respond: 

ICE estimates a total of 193 responses at 

1 hour (60 minutes) per response. 

(6) An estimate of the total public 

burden (in hours) associated with the 

collection: The total estimated annual 

hour burden is 193 hours. 

(7) An estimate of the total public 

burden (in cost) associated with the 

collections: $6,370. 

Dated: April 19, 2022. 

Scott Elmore, 

ICE PRA Clearance Officer. 

[FR Doc. 2022–08672 Filed 4–22–22; 8:45 am] 

BILLING CODE 9111–28–P 


khammond on DSKJM1Z7X2PROD with NOTICES